- EULAR •
- 5 June, 2026 •
- •
Updated population pharmacokinetic (popPK) model for emapalumab using data from four prospective clinical trials in patients with hemophagocytic lymphohistiocytosis/macrophage activation syndrome (MAS)
Patrick Brossard, Axel Facius, Brian Jamieson
Available materials